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ABSTRACT
Transcription of the phage Mu com/mom operon is
trans-activated by another phage gene product, C, a
site-specific DNA binding protein. To gain insight into
the mechanism by which C activates transcription, we
carried out footprinting analyses of Escherichia coli
RNA polymerase (= RNAP) binding to various com-lacZ
fusion plasmids. KMnO4-sensitive sites (diagnostic of
the melted regions in open-complexes) and DNase 1-
sensitive sites were located by primer-extension
analysis. The results are summarized as follows: (i) In
vivo, in the absence of C, RNAP bound in the wild-type
(wt) promoter region at a site designated P2; in vitro
DNase l-footprinting showed that P2 extends from - 74
to -24 with respect to transcription initiation. This
overlaps a known strong C-binding site (at -35 to
- 54). RNAP bound at P2 appeared to be in an open-
complex, as evidenced by the presence of
KMnO4-hypersensitive sites. (ii) In contrast, when C
was present in vivo, RNAP bound in the wt promoter
region at a different site, designated P1, located
downstream and partially overlapping P2. RNAP bound
at P1 also appeared to be in an open-complex, as
evidenced by the presence of KMnO4-hypersensitive
sites. (iii) Two C-independent mutants, which initiate
transcription at the same position as the wt, were also
analyzed. In vivo, in the absence of C, RNAP bound
mutant tin7 (contains a T to G substitution at -14)
predominantly at P1; in vitro DNase l-footprinting
showed that P1 extends from - 56 to + 21. With mutant
tin6 (a 63 base-pair deletion removing P2, as well as
part of P1 and the C-binding site from - 35 to - 54),
RNAP bound to P1 independent of C. We conclude that
P1 is the 'functional' RNAP binding site for mom-
transcription initiation, and that C activates
transcription by promoting binding at P1, while
blocking binding at P2.
INTRODUCTION
Studies on the expression of bacterial operons have shown that
transcription is regulated by a variety of intricate mechanisms.
The most thoroughly studied of these has been the interactions
of accessory proteins and RNA polymerase (RNAP) with
nucleotide (nt) sequences in the promoter region. Recent studies
have shown that multiple RNAP- and regulatory protein-binding
sites can also play a role in regulating transcription (1-4).
In phage Mu two overlapping genes, com and mom, are in
an operon for which multifaceted controls have evolved to tightly
regulate the production of the mom gene product (5). At the
transcriptional level, methylation of adenine residues in three
GATC sites upstream of the mom promoter by the E. coli
DNA-[N6-adenine]-methyltransferase (Dam) is required for
transcription (6-9). This methylation appears to prevent binding
of the E. coli OxyR protein, which has a recognition site in this
region and acts as a repressor when Mu DNA is not methylated
at these GATC's (10). Even when these sites are methylated a
phage-encoded transcriptional activator protein, C, is required
(11-13); C activates transcription at three other late promoters
as well. From an alignment of these four late promoter sequences,
a site important for C binding has been postulated (13). In vitro
DNase I-footprinting of C showed multiple binding sites in the
mom promoter region, including one site overlapping the -10
hexamer and spacer (-23 to -5), and one site 5' to and
overlapping the -35 hexamer (-52 to -33) (V.Nagaraja,
T.Gindlesperger, V.Balke, and S.Hattman, in preparation);
hereafter, these sites will be referred to as the -10 and -35
sites. Using MPE * Fe(Il) footprinting other workers observed only
the -35 binding site (14).
To help elucidate the mechanism by which C activates
transcription, we carried out footprinting analyses of E. coli
RNAP binding to various com-lacZ fusion plasmids in the
presence/absence of C. KMnO4-hypersensitive sites, diagnostic
of the melted regions in open-complexes (15), and DNase I-
sensitive sites were located by primer-extension analysis. The
results revealed the presence of two functionally distinct RNAP-
binding sites within the mom promoter region. In the absence
of C, RNAP bound predominantly at an upstream site (designated
P2) which overlaps the -35 binding site for C. Although RNAP
appeared to form an open-complex at P2, transcription in vivo
was severely reduced. When C was present in vivo, RNAP bound
to a different site, designated P1, located downstream from and
partially overlapping with P2. The results with two C-independent
mutants support the notion that P1 is the functional binding site
for mom transcription initiation.
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MATERIALS AND METHODS
Materials and general methods
Enzymes and linkers used for DNA cleavage and cloning were
purchased from New England Biolabs (NEB) or Bethesda
Research Laboratories (BRL). AMV reverse transcriptase
(RTase) (200 U/4d) and DNA sequencing kits were from United
States Biochemical (USB). RNase-inhibitor was from NEB and
DNase I was from Worthington Biochemical Corp. The Klenow
fragment ofDNA polymerase I (polIK) wasfrom both NEB and
Pharmacia. E. coli RNAP holoenzyme was a generous gift from
D. Hinkle and it was also purchased from Pharmacia.
Media and ,B-galactosidase assays were as described (16).
Standard protocols were used for plasmid isolation, restriction
digestions, ligation, plasmid transformation, gel electrophoresis
and electroelution of fragments from agarose gels (17). For DNA
ligation, fragments were isolated from gels using GenecleanTm
(Bio 101). Dideoxy-sequencing of DNA was with either [a-35S-
NTP] (10 mCi/ml; > 1000 Ci/mmol, Amersham) or [32P]-end
labeled primers. Primers were end-labeled using [Fy-32P]-ATP
(10 mCi/ml; > 5000 Ci/mmol, Amersham) and T4
polynucleotide kinase (NEB) according to the supplier's
instructions.
Hepes, DTT, PEG 8000, heparin and other chemicals were
from Sigma Chemical Co. Acrylamide solution for sequencing
gels was from National Diagnostics. Rifampicin and yeast tRNA
were from Sigma Chemical Co. The lac primer (NEB) is
complementary to the non-transcribed (top) strand; primer 2,
complementary to a vector sequence on the transcribed (bottom)
strand, was synthesized at the University of Rochester Sequencing
Facility. Prior to use the primers were passed through a PD-10
Sephadex G-25M column (Pharmacia).
Bacterial strains and plasmids
E. coli strain JM83 A(pro-lac) rpsL thi ara W80 dlacZ AM15
was purchased from BRL; strain LL306 A(pro-lac) nalA recA
supE44 thi was from L.Lindahl (18). E. coli GM1900, an F'
lacfq derivative of the prototroph, W31 10, was obtained from
M.Marinus. Expression vector, pKK223-3, was from Pharmacia
and pUC18 was from BRL. Plasmid pACYC184 (19) was
provided by L.Lindahl and pKN50 (20) was a generous gift from
M.M.Howe; the latter contains the phage Mu C gene and a
portion of the lys gene. All plasmids were isolated by the alkaline
lysis method (21) and purified by CsCl-EtBr centrifugation (17).
Plasmid pKN50 was linearized with HpaI; after the addition
of phosphorylated BamHI linker, the DNA was cleaved with
either BamHI or PvuI. In the former case, the fragment was
cloned into the BamHI site of pUC19 to produce pVN9. In the
latter instance, the resulting 3' ends were made blunt using T4
DNA polymerase. Following BamHI digestion and ligation of
XbaI linker to the blunt end, the DNA was cleaved with XbaI
and the C gene-containing 800 base pair (bp)-fragment was
purified after gel electrophoresis. It was then cloned into the
BamHI and XbaI sites of pUC 18. This plasmid was designated
pVN8. Plasmid pVN184 was constructed by cloning the
promoterless C gene-containing BamHI fragment from pVN9 into
the corresponding site (within the tet gene) in pACYC184; this
placed transcription of C under the tet promoter.
The mom-lacZ fusion plasmid, pMLF-2 (12), was propagated
in a dam- host. The plasmid DNA was isolated and cleaved at
the unique Bcll site within com. The 3' ends were removed by
fragment (containing the mom operon regulatory region and the
5' end of com) was gel purified and ligated into the EcoRI/Smal
sites of pNM480 (21). This construct (designated pLW4)
produces a com-lacZ protein-fusion only in the presence of C
(unpublished observation).
Isolation of fin mutants
Approximately 4 x 108 cells of E. coli JM83 [pLW4] were
spread on MacConkey-lactose-ampicillin apr plates and red
papillae were purified by streaking. Plasmid DNA from
minipreps (21) was analyzed by restriction nuclease digestion to
screen for detectable insertions or deletions. Nucleotide sequence
anaylsis was used to define the precise mutational alteration.
Construction of single-copy com-lacZ fusion X prophages
The procedures used were essentially those described by Simons
et al (24). In brief, the 223 bp EcoRIIBamHI fragments from
pLW4, pLW4tin6 and pLW4fin7, respectively, were cloned into
the corresponding sites of pRS552 and tan d into E. coli
JM83 (selecting for KmR clones). The resuling plasmids were
designated pRSW, pRST6 and pRST7, respectively. XRS4S plate
lysates were prepared on these strains ail the phage used to
transduce E. coli LL306 to KmR. Trnduant clones were
screened to distinguish between monolysogens and dilysogens;
wt, tin6 and uin7 monolysogens were designated XRS::RSW,
XRS::RST6 and XRS::RST7, respectively.
Primer extension of mom mRNA
E. coli strain LL306 transfonned with either pLW4 i pVN184,
pLW4tin6 or pLW4tin7 was grown in 25 XI of L-broth to mid-
log phase. Total cellular nucleic acids were isolated (25) and 4
,d (10 gg) of nucleic acid was added to 2 id of RTase buffer
(250 mM Tris HCI, pH 8.3, 500 mM KCI, 50 mM MgC12, 5
mM DTT, 5 mg/ml bovine serum albumn. After the addition
of LIA (750,000 cpm) of end-labeled lac priner and 1 Ad of RNase
Inhibitor, the primer was allowed to hybridize for 2 hr at 42°C.
Then 1 p1 (200 U) of AMV RTase and 1 pd of dNTP mix (20
mM) were added and the reaction allowed proeed for 1 hr
at 370C. After the addition of 2 pl of Stop-Dye Mix (0.1% xylene
cyanol, 0. % bromophenol blue, 10 mM EDTA, 95% deionized
formamide), the samples were diluted 1:4, heated at 95°C for
2 min and subjected to electrophoresis in a 6% thick
polyacrylamide sequencing gel.
In vitro transcription
The 223 bp EcoRI-BamHI fragment from pLW4tin7was isolated
by electroelution from an agarose gel. Theranscription assay
(26) was as follows. Approximately 50 ng of fragments were
brought to a final volume of 25 yd with the addition of 5 u1 of
5 xtranscription buffer (600 mM KCI, 50 mM MgCl2, 0.5 mM
DTT, 0.5 mM EDTA, 50mM Tris HCI, pH 8.0, 25% glycerol),
2.5 1l NTP mixture and 5 yCi or either [y-32P]-ATP or
['y-32P]-GTP (10 mCi/ml; > 1000 Ci/mmol, Amersham). The
final concentration of the NTP corresponding to the radioactive
nt was 0.2 mM, while the three other nts were at 3 mM. The
mixtures were incubated for 3 min at 37°C and then 1 1l of
RNAP was added. After S min the concentaflion of the more
dilute radioactive nt was increased to 3 mM by the addition of
1 of 7.5 mM NTP. The reaction was continued for an
additional 10 min, then 5 yd of Stop-Dye Mix was added and
the samples were subjected to electrophoresis in a 6%
Sl nuclease digestion. After cleavage with EcoRI, the 223 bp polyacrylamide gel.
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KMnO4-Footprinting
Slight modifications of published protocols (15) for in vivo and
in vitro treatment with KMnO4 were followed. Cultures of
LL306 transformed with the appropriate plasmid(s) were grown
in M9-glucose-ampicillin medium supplemented with 20 mg/ml
casamino acids. When the culture reached mid-log phase, it was
divided into two 10 ml aliquots and one was treated with 200
lAg/ml rifampicin for 5 min (to trap RNAP in the open-complex).
Then both samples were treated with KMnO4 for 4 min and
poured into 30 ml Corex tubes containing crushed ice. Plasmid
DNA was isolated as described (17) except that the samples were
extracted once with phenol prior to precipitation with 2-propanol.
For in vitro footprinting of RNAP, 2 Ag of plasmid DNA were
brought to 16 Al in Hepes transcription buffer (10 mM Hepes,
pH 7.6, 0.1 mM EDTA, 10 mM MgCl2, 4 mM CaCl2, 1 mM
DTT, 3% glycerol, 2% PEG 8000). After 3 min incubation at
37°C, 1 Al RNAP (previously diluted 1:10 to 8 /tM in 1 x Hepes
buffer) was added. RNAP was allowed to form complexes for
3 min at 37°C prior to the addition of 4 Al of 100 mM KMnO4.
After 4 min incubation at 37°C, 3 itl of ,3-mercaptoethanol (14.7
M) was added to quench the KMnO4. The samples were passed
through a Sephadex G50-80 spin column equilibrated with water
and the DNA precipitated by the addition of 4 Al 3 M sodium
acetate, 3 ,ul 5 mg/ml carrier yeast tRNA and 100 I1L 95% ethanol.
The DNA was resuspended in 75 A1 of doubly distilled H20
prior to the primer extension reaction (see below).
DNase I-footprinting
Two Ag (0.34 pmole) of plasmid pLW4 or pLW4tin7 was
incubated with RNAP (12 to 24 pmol) in footprinting buffer (10
mM Hepes, pH 7.6, 0.1 mM EDTA, pH 8.0, 10 mM MgCl2,
4 mM CaCl2, 1 mM DTT, 3% glycerol, 60 mM KCl and 2%
PEG 8000). After 5 min at 22°C, 1 pl of DNase I (1 mg/ml
in footprinting buffer) was added to the reaction mix for 1 min
at 22°C. The reactions were stopped by the addition of 20 ml
Stop Buffer (150 mM NaCl, 15 mM EDTA, 50 mM Tris-HCl,
pH 7.5, 0.3% SDS). The samples were extracted successively
with phenol, phenol/chloroform, chloroform and then precipitated
with ethanol and washed. The DNA was resuspended in 70 1l
of water and divided into two aliquots. Each aliquot was incubated
with a separate end-labeled primer complementary to the top or
bottom strand. After alkali denaturation at 80°C, the primer was
annealed at 50°C in 0.05 M Tris (pH 7.2), 0.01 M MgSO4, 0.2
mM DTT. After the addition of 5 mM dNTP, 1 A1 of polIK (1
unit) was added and primer extension reactions were carried out
(see below).
Primer extension
The lac primer, which hybridizes within the lac gene of the com-
lacZ fusion, was used to probe modification/cleavage of the top
strand, and primer 2 was used to probe the bottom strand. Primer
extension reactions were as described (27, 28). Hybridizations
were carried out at 50°C when using the lac primer and 45°C
for primer 2. After precipitation, the extension products were
resuspended into 4 pL1 of Stop-Dye Mix and heated for 2 min
at 95°C prior to gel electrophoresis.
RESULTS
Isolation of tin mutants
To facilitate studies on the interaction of RNAP with the
com/mom-operon promoter region, we constructed the com-lacZ
fusion plasmid, pLW4. Cells harboring pLW4 alone do not
contain any ,B-galactosidase activity due to the absence of Mu
C protein, which is required for transcription. This property
allowed us to screen for the production of mutations in pLW4
(induced or spontaneous) that led to C-independent transcription
and production of the com-lacZ fusion protein, as evidenced by
the appearance of red papillae over bacterial lawns plated on
MacConkey-lactose agar. Plasmid DNA from spontaneous
mutants was taken for restriction nuclease and nt sequence
analysis; two mutations are described in detail. One (tin7) is a
T to G transition (corresponding to nt 985 from the right end
of the Mu genome) within a T6-run at -14 with respect to the
transcription start site. Another (in6), a 63 nt deletion from -32
to -94, has removed both the -35 binding site for C and the
-35 hexamer of the mom promoter (Fig. 1). The formation of
tin6 and tin7 appears to be highly favorable since they both
appeared in other mutant screens (S.Hattman and J.Ives,
unpublished; V.Balke, unpublished).
tin6 [ 1
-120 -110 -100 -90
-80 -70
TATAAAAAACACCCCGCGAAACGAGCGCATATAGAAACGA CM;AATCAATTAAATcw3
Uin7
C-bindinq site G comn-mom mRNA
-60 -50 -40 -30 -2 -10
GGTAATACA;IG3ATTATGCCCCAATAACCACJTCAACCCATGATGTTTITTAAGATAGTGGCGAATTGA
xxxxxxxxx xxxxxxxxx
-35 -10
I tin6 deletion
TAGACTcAAcccATGATGrmrTAAGAT
xxxxxxxxx xxxxxxxxx
-35 -10
Fig. 1. Mu mom promoter region nucleotide sequence; this corresponds to the top strand referred to in Fig.6. The -35 and - 10 hexamers are underscored with
x's. The tin7 mutation is a T to G substitution at position - 14 with respect to the transcription start site. The tin6 mutation is a 63 nt deletion (within brackets);
the junction created by the deletion forms an improved -35 sequence and spacer length (17 nt), as shown at the bottom. The C-binding site at -35 is denoted
by the open bar; Dam methylation sites, GATC, are enclosed in rectangles.
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3-galactosidase production by various com4acZ prophage
fusions
The level of fl-galactosidase was determined for cells containing
various forms ofpLW4 present as single-copy com-lacZprophage
fusions. These constructs were made in order to avoid possible
differences in copy-number and maintaining two different
plasmids in the same cell. ,B-galactosidase levels in lysogens
XRS::RSW (wt), XRS::RST6 (tin6) and XRS::RST7 (tin7) with
or without a C-producing plasmid, pVN8, were measured.
Comparison of the enzyme levels (Table 1) showed that, in the
absence of C, the tin6 and tin7 lysogens produced 7 and 2-fold
more enzyme, respectively, than the wt alone. When the C-
producing plasmid, pVN8, was present both the wt and tin7
prophages were transactivated to similar levels; in contrast, tin6
was not transactivated, which is consistent with the fact that the
-35 C-binding site is deleted in this mutant. Although tin7 was
expressed in the absence of C (albeit weakly compared to tin6),
it was transactivated to a level about 50% higher than tin6 or
the C-activated wt.
Transcription start site in the tin mutants
Previous experiments with SI nuclease mapping led to different
assignments of the transcription start site in the mom promoter
region (29, 30). More recent studies (14) indicated the start site
to be at one oftwo possible nts, but different from either of those
previously reported. Therefore, an alternative method to
determine the start site was undertaken, namely, primer extension
with RTase. To study transcription from the wt promoter, cells
were transformed with both pLW4 and the compatible C-
producing plasmid, pVN184. RNA was isolated from these cells,
as well as from cells containing pLW4 alone. After hybridization
of end-labeled lac primer and extension with RTase, the products
were analyzed by gel electrophoresis (Fig. 2). In the absence of
C, pLW4 produced barely detectable levels of com-lacZ mRNA
(lane 2). However, when an excess of RNA was analyzed, we
did observe some com-lacZ mRNA transcripts (lane 1), some
of which appear to have initiated at the proposed wt promoter
(band corresponding to nt 971). In contrast, when C was present
extensive transcription ofpLW4 occurred, with the predominant
band occurring at position 971 (lane 3). Analysis ofmRNA from
cells containing either pLW4tin6 (lane 4) or pLW4tin7 (lane 5)
showed that they also initiated at nt 971. [This position of the
start-site is several nt upstream from the one we deduced by SI
nuclease protection analysis (29). Examinton of the original
autoradiograms revealed that we had discounted the importance
of a 'smear' of longer fragments that, in ret , must have
reflected continued SI nuclease digestion of the AT-rich end.]
The relative levels of transcripts produced by the duee promoters
correlates well with those of (3-galactosidase activity (Table I).
These results are consistent with the proposed -35 and -10
promoter hexamer sequences (Fig. 1) and they show that a new
tranription start site was not generated in either mutant.
In order to verify that transcription starts at it 971 (a G), in
vitro transcription assays were done using- either I'y-32P1 ATP
or [(y-32P] GTP. Under these conditions, the only transcripts
labeled should be those that have incorponrted the [-y-32p] label
at the 5' end. RNAP was allowed to rnsribe offa tin7 fiagMnt
in the presence of either [y-32P] ATP or [y-32P] GTP; we
observed that only [-y-32P] GTP produced labeled mom transcript
(data not shown). This confirms that the start site is G971.
Hereafter, all nt positions will be numbered by their position
relative to the transcriptional start site, which is defined as + 1.
In vivo KMnO4-footprintIng of open-complexes
The above results indicated that transcription of the wt promoter
was strongly reduced when C was not present. This is not
surprising in view of the poor homology to consensus and the
suboptimal spacing between the -10 and -35 hexamers.
Therefore, it was of considerable interest to study the binding
1 2 3 4 5 C T A G
971-
Table I. Production of (3-galactosidase activity in E. coli LL306 by various single-
copy com-lacZ prophage fusionsa
Strainb 13-galactosidase activityc
(Miller units)
(XRS::RSW) 24+ 6
(XRS: :RSW)[pVN8] 137 + 20
(XRS::RST6) 163+26
(XRS::RST6)[pVN8] 156 + 32
(XRS::RST7) 42+6
(XRS::RST7)[pVN8] 222 34
a Overnight cultures grown in LB + kanamycin + ampicillin were diluted 1:50
into fresh medium at 37°C and grown to log phase. Aliquots were taken for assay
of i3-galactosidase and optical density; corrections for the contribution of LB to
the optical density were made in each case.
b Prophages are denoted as follows; W=wt; T6=tin6; T7=tin7.
c The values represent the mean SD from three independent experiments in
which triplicate assays were done for each culture.
Fig. 2. In vivo analysis of mom-transcription initiation by primer extension with
RTase. RNA from various plasmid-containing cells was isolated and the 5' end
of the mm-specific trnscripts analyzed. Lanes I & 2, pLW4 alone; lane 3, pLW4
and pVN184; lane 4, pLW4tin6; lane 5, pLW4tin7. Lae 1 contained a 20-fold
higher anount of RNA than analyzed in lanes 2-5. C, T, A, G refer to the
top strand sequence, derived from reactions with the complementary
dideoxynucleotides.
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of RNAP to the wt and tin promoters, as well as the effect of
C. This was accomplished through an in vivo footprinting analysis
with KMnO4. Because this agent preferentially attacks
pyrimidines in single-stranded DNA, it is a useful probe for open-
complexes (31).
Cells transformed with pLW4wt, pLW4tin6 or pLW4tin7 were
treated with KMnO4 in the absence or presence of rifampicin [in
order to trap RNAP in an open-complex (15)]. Plasmid DNA
was isolated and, after hybridization and extension of end-labeled
primers, the products were analyzed by polyacrylamide gel
electrophoresis to determine the sites of modification on each
of the two strands (results for the top strand are shown in Fig. 3;
+ RNAP denotes addition of rifampicin). In the presence of
rifampicin, there were sites of strongly enhanced KMnO4
sensitivity (hypersites) at positions -47 and -41 on the top strand
of pLW4wt (compare lanes 1 and 2). Because the appearance
of these hypersites was dependent on the presence of rifampicin,
we conclude that RNAP binding was required. The location of
wt tin 7 tin 6
RNAP - + - + -+ - ± + - +
C - + + + - - + +
-441
-41 9**A-41 § &k I*
..4 .
.AWI: t * . M6
**^ ** a^=
~~~~~~~~.
1 2 3 4 5 6 7 8 9 10 1112
Fig. 3. In vivo analysis of KMnO4-sensitive sites (top strand) on wt and tin
plasmid DNAs. DNA was isolated from pLW4-containing cells [without or with
plasmid pVN 184 to provide C protein (indicated with a + on the appropriate
line)] after treaftment with KMnO4 and analyzed by primier-extension sequencing.
In this experiment, rifampicin had to be added in order to trap RNAP in the open-
complex; + RNAP and - RNAP denote presence and absence of the drug,
respectively.
the hypersites is suggestive of RNAP binding at a site upstream
from the proposed -10 and -35 hexamers (Fig. 1). Strong
support for this was obtained from in vitro analyses presented
below; we designate this upstream binding site as P2. In vivo
binding of RNAP to the wt DNA in the presence of C was
investigated by probing cells that had been transformed with both
pLW4 and the C-producing plasmid, pVN184. In this instance,
treatment with KMnO4 produced hypersites at -4 and -3, as
well as a weak enhancement at +5 (lane 4). Modification at these
positions is consistent with RNAP binding to a site, designated
P1, corresponding to an active promoter. Support for this came
from analyzing the in vivo binding of RNAP to plasmids
pLW4tin6 and pLW4in7. For example, in the absence of C,
hypersites corresponding to P1 were produced on tin7 at -4,
-3 and +5 (lane 6); in addition, some KMnO4-modification
was still seen at -47 and -41. These results indicate that there
may be competition for RNAP binding at P1 and P2. In the
presence of C, RNAP bound predominantly to P1 (lane 8). With
tin6 (lanes 10 and 12), only P1 hypersites were observed. This
result was expected since P2 and the -35 C-binding site are
deleted in this mutant. It should be noted that modification of
the + 5 site was reduced in the presence of C (compare lanes
6 and 8, and lanes 10 and 12).
In vitro KMnO4 and DNase I-footprinting of RNAP
In order to confirm the existence of the two RNAP-binding sites,
P1 and P2, an in vitro KMnO4-footprinting analysis was carried
out. RNAP was bound to supercoiled wt and tin7plasmid DNAs
in the absence of added nucleotides, and the complexes were
probed with KMnO4. On the wt promoter, hypersites were
observed at -47 on the top strand, and at -55, -57 and -62
on the bottom strand (Fig. 4; compare the lanes marked - and
+ denoting absence and presence of RNAP, respectively). In
contrast, with pLW4tin7, hypersites were observed at -4, -3
and +5 on the top strand, and at -10 and -11 on the bottom
TOP STRAND
wt tin 7
-+ C A G -+
-47-
-4
.m_
+5-~~~~~~~5
'e
* XE -4 ,.
a"_
-4* _4,
..
_
BOTTOM STRAND
wt tin7
-+ G A T C - +
Xi I
T4~~&it -~-57
<6
1E _
1L_
Fig. 4. In vitro analysis of KMnO4-sensitive sites on the top and bottom strands
of wt and in7plasmid DNAs. The symbols + and - denote addition and omission
of RNAP, respectively. Sequencing lanes C, A, G and T are shown.
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A
-90 -80 -70 -60 -50 A
-40
ATAGAAAACGACGATCGAATCAATTAAATCGATCGGTAATACAGATCGATTATGCCCCAAT
TATCTTTTGCTGCTAGCTTAGTTAATTTAGCTAGCCATTATGTCTAGCTAATACGGGGTTA
V V V
corn-mom mRNA
-30 -20 A +1 AA +10 +20
A
~ TCAACCCATGATGTTTT ~ GTGGCGAATTGATGCAAAGGAGGTGAGA
TTGGTGTGAGTTGGGTACTACAAAAAATTCTATCACCGCTTAACTACGTTTCCTCCACTCT
VV
Fig. 5. Summary of footprinting with KMnO4 and RNAP in the mom promoter region. KMnO4-modified sites are indicated with one caet (mnodeae sensitivity)
or two carets (high sensitivity). The -10 and -35 sequences in P1 (top strand) are enclosed in rectangles; putative -10 and -35 sequences in P2 are overlined
(top strand) or underlined (bottom strand).
strand; these sites are characteristic of open-complexes at known
functional promoters. A composite of the in vivo and in vitro
KMnO4-sensitive sites is shown in Fig. 5.
To further investigate RNAP binding to the mom-promoter
region, we carried out an in vitro DNase I-footprinting analysis
(32). RNAP was bound to wt and tin7 plasmid DNAs and the
complexes were incubated with DNase I; cleavage sites were
identified by extension of end-labeled primer and gel
electrophoresis. It is clear from the results (Fig. 6) that different
patterns of DNase I cleavage were observed with the two
substrates. The DNase I-footprint corresponding to P2 on the
wt extends from -74 to -24 (on the top strand); the P1 region
on tin7 spans from -56 to +21. Moreover, in addition to
protection against DNase I action, there was also some
enhancement of cleavage, particularly at several sites on tin7
DNA. It is interesting to note that, even in the absence of added
RNAP, the wt and tin7 DNAs exhibited different sensitivities
to DNase I cleavage in the 'spacer' region between the -10 and
-35 sequences. In fact, we have also observed differences to
other chemical modifications in this region (unpublished).
These results indicate that in the absence of the transcriptional
activator protein C, RNAs capable of binding in vitro to the wt
mom promoter region. Based on its sensitivity to KMnO4 it
appears that RNAP formed an open-complex, or one that had
some conformational distortion allowing access to this agent.
However, binding at this site, designated P2, is different from
the one on tin7 DNA, designated P1, which appears to be the
functional RNAP-binding site for the mom promoter. Lastly, it
should be noted that because P2 and P1 overlap, it is likely that
RNAP bound in P2 precludes recognition of P1.
DISCUSSION
Isolation and characterization of C-independent (#in) mutants
Transcription from the Mu mom promoter requires both the
activity of the host Dam DNA-methyltransferase and the phage-
encoded protein, C. It is known that C is a DNA-binding protein
specific for the Mu late promoters (14, 33; Nagaraja et al., in
preparation), but its precise role remains to be defined. As with
several other prokaryote promoters requiring an accessory
transcription factor, the Mu mom promoter has relatively poor
homology to the consensus E. coli promoter sequence.
Furthermore, a T6-run in the spacer may affect transcription due
to its intrinsic bending potential (34).
In this paper, we have described the isolation and
characterization of two mutations in the mom-promoter region
which allow C-independent transcription. In both cases, the
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Fig. 6. In vitro DNase I-footprinting of RNAP. Plasmnids pLW4 and pLW4tin7
(2 #g; 0.34 pmole) were incubatd in the absence or presence of RNAP (12 pmole)
and treated with DNase I. Cleavage sites on the top strand were mapped by
extension with end-labeled primer and sequencing gel clectrophoresis; control
sequencing lanes are not shown. Assuming the plmids contain only four
promoters and that the RNAP preparation was 100% active, then the RNAP:mom
promoter ratio was 9; both assumptions are likely to be conservative. The vertical
brackets denote the regions of RNAP protection.
transcriptional start site (G971) of the C-activated wt promoter
was conserved. In tin7, a T to G substitution has converted a
T6-run (adjacent to the -10 hexamer) to T30T2, abolishing any
intrinsic bending potential of this sequence (34). Additionally,
the base substitution created a TG at -15, -14, a situation that
has been observed to relieve dependence on accessory
transcription factors for a number of other E. cE p rs (35,
36), although not in all cases (37). It has been suggested that
DNA kinks may be readily introduced at TG/CA base pairs
following binding of the E. coli CAP protein (38). Thus, it is
it;I r
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possible that RNAP binding to the tin7 promoter introduces a
kink at the TG, and that facilitates formation of new and improved
RNAP contacts with residues in the -10 region. If this is so,
then it would be worthwhile to determine whether RNAP binding
alone induces a kink in those promoters which respond to a TG
mutation at -15, -14.
In previous studies we isolated a series of spontaneous tin
mutations in a mom-lacZ multi-copy plasmid (S.Hattman and
J.Ives, unpublished results). Many of these contained single base-
substitutions scattered throughout the promoter region from -126
to -11. None produced enzyme levels as high as tin6 or tin 7,
although the specific activity varied over a 20-fold range. These
have not yet been examined further, but it is evident that
modulation of mom expression can be affected by mutations at
many sites. Further studies are important to determine the effect
of these mutations on RNAP binding at P1 and P2.
Footprinting of RNAP
We have used wt and tin derivatives of com-lacZ fusion plasmids
to investigate the interaction of RNAP with the mom promoter
region. To this end, DNase I-protection and KMnO4-sensitivity
analyses were carried out to probe for the presence of RNAP
in the open-complex. The results of these studies are summarized
as follows: (i) In the absence of C, RNAP bound to the wt
promoter in vivo at a site (designated P2), which overlaps the
-35 binding site for C. (ii) In contrast, when C was present in
vivo, RNAP bound to the wt promoter at a different site,
designated P1, located downstream and partially overlapping P2.
(iii) In the absence of C, RNAP bound to the tin7 promoter
predominantly at P1 in vivo and in vitro. With mutant tin6 (a
63 base-pair deletion removing P2, part of P1 and the C-binding
site), RNAP bound to P1 independent of C. (iv) Based on the
patterns of protection/sensitivity to DNase I, the boundaries of
P1 and P2 are from -56 to +21 and -74 to -24, respectively.
The results of ,B-galactosidase assays on single-copy com-lacZ
prophage fusions were consistent with those of the
KMnO4-footprinting. The level of f-galactosidase activity for
tin6 was independent of C, and it was as high as the C-activated
wt (Table I). On the other hand, the tin7 promoter was only
slightly active in the absence of C, but was transactivated to a
level 40 to 50% higher than that of tin6 or the C-activated wt.
These results raise the possibility that the T6-run plays a role in
limiting the level of transcription from the mom promoter.
Intrinsic curvature at this site in the DNA may occur in a direction
that is unfavorable for RNAP binding, and it might magnify the
disadvantage of having a 19 nt spacer.
The role of C
In contrast to a previous report (14), we have observed that C
binds at other sites in addition to the -35 site; viz. at a site
overlapping the -10 hexamer and spacer, as well as two
additional sites flanking the -10 and -35 regions (Nagaraja et
al., in preparation). We believe that C binds the -10 and -35
sites on the same face of the DNA helix because they are
separated by about one helical turn. From the results presented
here, we conclude that P1 is the 'functional' RNAP binding site
for mom-transcription initiation, and that C activation blocks
RNAP binding at P2 as well as promoting binding at P1.
Considering that the binding sites for the two proteins overlap
(probably on different faces of the DNA helix), specific C-RNAP
interactions are likely to be involved in the activation process.
or prevent RNAP binding in P2 (directly by steric hindrance or
indirectly by alteration of the DNA conformation). Alternatively,
a C-RNAP complex might displace the RNAP bound at P2. It
is not known if C binding at the -35 site alone is sufficient to
activate transcription, or whether C binding at the -10 site is
also required. Since we are only at the beginning of our
investigation of mom transcriptional activation, further studies
are necessary to elucidate the molecular details of these
interactions.
What is the nature of the RNAP-P2 complex?
The pattern of KMnO4-hypersites and their rifampicin-
dependency in vivo suggest that RNAP bound at P2 (in the wt
promoter region) was in an open-complex. Within this region
there are several sequences which would probably make relatively
poor promoters, thus making the exact placement of P2 difficult.
However, in vitro footprinting with DNase I showed that RNAP
protected the wt promoter between -74 to -24, whereas the
tin7 promoter was protected from -56 to +21. Accordingly,
the best promoter sequence for P2 on the top strand would be
TTAAAT ('-35') near -73 and GATTAT ('-10') near -50, with
an 18 nt spacer (overlined in Fig. 5). Although RNAP appears
to be in an open-complex, in vivo (rightward) transcription from
this region was reduced more than 50-fold compared to the C-
activated promoter (Fig. 2, lanes 1-3). Therefore, if the RNAP-
P2 complex is transcriptionally competent, then the mRNA must
be terminated prematurely or rapidly degraded or be in the
leftward direction (this would not have been detected because
of the nature of the primer employed). In this regard, Margolin
et al (13) reported that there is a sequence in the mom promoter
region that can serve as a C-independent leftward promoter when
fused to lacZ in the appropriate reading frame; but, detailed in
vivo studies of Mu development have failed to show any leftward
transcription from this region (39). It is interesting to note that
the bottom strand has a TTGAGT ('-35') and a CATAAT ('-10')
(underlined in Fig. 5). Although these hexamers have reasonable
homology to the consensus, they are separated by a suboptimal
spacer length of 13 nt. Clearly, further studies are needed to
determine the exact nature of the RNAP-DNA complex at P2.
Why does RNAP bind to the wt mom promoter at P2 when
C protein is not present? Inasmuch as Mom modification is a
'late' function and one which appears to be cytotoxic if expressed
at the wrong time (5), then binding to the P2 site may serve as
an additional transcriptional control. That is, P2 may act as a
'sink' for RNAP binding in the absence ofC that would minimize
chance rightward transcription.
Bacteriophage Mu has evolved a series of intricate mechanisms
to regulate gene expression. From the results reported here, there
appear to be additional facets of transcriptional regulation; viz.
DNA structure and the presence of alternative, functionally
distinct binding sites for RNAP influence the availability of the
mom promoter. In this regard, C probably has dual functions
in its role as a transcriptional activator of mom transcription; i.e.
it prevents binding of RNAP at P2 and activates binding at P1.
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